JOINTOWN PHARMACEUTICAL GROUP CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.21 CNY | 0.00% |
|
-3.86% | +17.12% |
ETFs positioned on Jointown Pharmaceutical Group Co., Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.42% | 2 M€ | -16.59% | - | |
| 0.06% | 11 M€ | +1.79% | ||
| 0.03% | 4 M€ | -11.56% | ||
| 0.00% | 2,808 M€ | +5.90% | - | |
| 0.00% | 441 M€ | +4.60% | - | |
| 0.00% | 149 M€ | +2.17% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 31 M€ | +3.50% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 15 M€ | +11.24% |
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
8.21
CNY
Average target price
10.18
CNY
Spread / Average Target
+24.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.12% | 4.31B | |
| +17.35% | 71.39B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B | |
| +7.96% | 3.29B |
- Stock Market
- Equities
- 600998 Stock
- Funds and ETFs Jointown Pharmaceutical Group Co., Ltd
